Primary bone lymphoma the university of miami experience

Leukemia and Lymphoma

Volumn 51, Issue 1, 2010, Pages 39-49

  Alencar, Alvaro ^a   Pitcher, David ^b   Byrne Jr , Gerald ^a   Lossos, Izidore S ^a,c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

Bone lymphoma; Combination chemo radiation; Rituximab

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; METHYLPREDNISOLONE; MITOXANTRONE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ARTICLE; BACTERIAL PNEUMONIA; BONE CANCER; BONE NECROSIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG MEGADOSE; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OSTEOMYELITIS; PATHOLOGIC FRACTURE; PNEUMOCYSTIS PNEUMONIA; PRIMARY BONE LYMPHOMA; PRIMARY TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; BONE NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FLORIDA; FOLLOW-UP STUDIES; HUMANS; IMMUNOTHERAPY; LYMPHOMA; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 74949094509     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428190903308007     Document Type: Article

References (60)

1. Oberling C. Les reticulosarcomes et les reticuloendotheliosarcomes de la moelle osseuse (sarcomes d'Ewing). Bull Assoc Fr É tude Cancer 1928;17:259-296.
2. Parker F, Jackson H. Primary reticulum cell sarcoma of bone. Surg Gynecol Obstet 1939;68:45-53.
3. Dahlin DC, Unni KK. Bone Tumors: General Aspects and Data on 8,542 Cases. Springfield, IL: Charles C. Thomas Publisher Limited; 1986. p 538.
4. Limb D, Dreghorn C,Murphy JK, et al. Primary lymphoma of bone. Int Orthop 1994;18:180-183.
5. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972;29:252-260.
6. Rosenberg SA, Diamond HD, Jaslowitz B, et al. Lymphosarcoma: A review of 1269 cases. Medicine (Baltimore) 1961;40:31-84.
7. Dubey P, Ha CS, Besa PC, et al. Localized primary malignant lymphoma of bone. Int J Radiat Oncol Biol Phys 1997;37: 1087-1093.
8. Coley BL, Higinbotham NL, Groesbeck HP. Primary reticulum-cell sarcoma of bone; summary of 37 cases. Radiology 1950;55:641-658.
9. Ferreri AJ, Reni M, Ceresoli GL, et al. Therapeutic management with adriamycin-containing chemotherapy and radiotherapy of monostotic and polyostotic primary non-Hodgkin's lymphoma of bone in adults. Cancer Invest 1998;16:554-561.
10. Shoji H, Miller TR. Primary reticulum cell sarcoma of bone. Significance of clinical features upon the prognosis. Cancer 1971;28:1234-1244.
11. Fletcher CDM, Unni KK, Mertens F, editors. Pathology and Genetics of Tumors of Soft Tissue and Bone: World Health Organization Classification of Tumours. Lyon, France: IARC Press; 2002. p 427.
12. Jaffe ES, Harris NL, Stein H, et al. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001. p 351.
13. Ostrowski ML, Unni KK, Banks PM, et al. Malignant lymphoma of bone. Cancer 1986;58:2646-2655.
14. Ramadan KM, Shenkier T, Sehn LH, et al. A clinicopathological retrospective study of 131 patients with primary bone lymphoma: A population-based study of successively treated cohorts from the British Columbia Cancer Agency. Ann Oncol 2007;18:129-135.
15. Lewis V, Primus G, Anastasi J, et al. Oncologic outcomes of primary lymphoma of bone in adults. Clin Orthop Relat Res 2003;415:90-97.
16. Heyning FH, Hogendoorn PC, Kramer MH, et al. Primary non-Hodgkin's lymphoma of bone: A clinicopathological investigation of 60 cases. Leukemia 1999;13:2094-2098.
17. Mulligan ME, McRae GA, Murphey MD. Imaging features of primary lymphoma of bone. AJR Am J Roentgenol 1999; 173:1691-1697.
18. Maruyama D, Watanabe T, Beppu Y, et al. Primary bone lymphoma: A new and detailed characterization of 28 patients in a single-institution study. Jpn J Clin Oncol 2007;37:216-223.
19. Ueda T, Aozasa K, Ohsawa M, et al. Malignant lymphomas of bone in Japan. Cancer 1989;64:2387-2392.
20. Copie-BergmanC,NiedobitekG,ManghamDC, et al. Epstein- Barr virus in B-cell lymphomas associated with chronic suppurative inflammation. J Pathol 1997;183:287-292.
21. McGrory JE, Pritchard DJ, Unni KK, et al. Malignant lesions arising in chronic osteomyelitis. Clin Orthop Relat Res 1999:181-189.
22. Baar J, Burkes RL, Bell R, Blackstein ME, Fernandes B, Langer F. Primary non-Hodgkin's lymphoma of bone. A clinicopathologic study. Cancer 1994;73:1194-1199.
23. Fidias P, Spiro I, Sobczak ML, et al. Long-term results of combined modality therapy in primary bone lymphomas. Int J Radiat Oncol Biol Phys 1999;45:1213-1218.
24. Gianelli U, Patriarca C, Moro A, et al. Lymphomas of the bone: A pathological and clinical study of 54 cases. Int J Surg Pathol 2002;10:257-266.
25. SteinME, Kuten A, Gez E, et al. Primary lymphoma of bone - a retrospective study. Experience at the Northern Israel Oncology Center (1979-2000). Oncology 2003;64:322-327.
26. Isaacson PG, Norton AJ. Extranodal Lymphomas. Edinburgh, New York: Churchill Livingstone; 1994.
27. Jones D, Kraus MD, Dorfman DM. Lymphoma presenting as a solitary bone lesion. Am J Clin Pathol 1999;111:171-178.
28. Stansfeld AG, Diebold J, Noel H, et al. Updated Kiel classification for lymphomas. Lancet 1988;1:292-293.
29. Carbone PP, Kaplan HS, Musshoff K, et al. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971;31:1860-1861.
30. Shipp MA, Harrington DP, Anderson JR, et al. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993;329:987-994.
31. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-655.
32. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002;346:235-242.
33. Coiffier B, Lepage E, Herbrecht R. Mabthera (rituximab) plus CHOP is superior to CHOP alone in elderly patients with diffuse large b-cell lymphoma (DLBCL): interim results of a randomized GELA trial. Blood 2000;96:223a.
34. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
35. DeAngelis LM, Yahalom J, Thaler HT, Kher U. Combined modality therapy for primary CNS lymphoma. J Clin Oncol 1992;10:635-643.
36. Dosoretz DE, Raymond AK, Murphy GF, et al. Primary lymphoma of bone: the relationship of morphologic diversity to clinical behavior. Cancer 1982;50:1009-1014.
37. Bacci G, Ferraro A, Casadei R, et al. Primary lymphoma of bone: long term results in patients treated with vincristine- adriamycin-cyclophosphamide and local radiation. J Chemother 1991;3:189-193.
38. Rathmell AJ, Gospodarowicz MK, Sutcliffe SB, et al. Localised lymphoma of bone: prognostic factors and treatment recommendations. The Princess Margaret Hospital Lymphoma Group. Br J Cancer 1992;66:603-606.
39. Fairbanks RK, Bonner JA, Inwards CY, et al. Treatment of stage IE primary lymphoma of bone. Int J Radiat Oncol Biol Phys 1994;28:363-372.
40. Bayrakci K, Yildiz Y, Saglik Y, et al. Primary lymphoma of bones. Int Orthop 2001;25:123-126.
41. de Camargo OP, dos Santos Machado TM, Croci AT, et al. Primary bone lymphoma in 24 patients treated between 1955 and 1999. Clin Orthop Relat Res 2002:271-280.
42. Marshall DT, Amdur RJ, Scarborough MT, et al. Stage IE primary non-Hodgkin's lymphoma of bone. Clin Orthop Relat Res 2002:216-222.
43. de Leval L, Braaten KM, Ancukiewicz M, et al. Diffuse large B-cell lymphoma of bone: An analysis of differentiationassociated antigens with clinical correlation. Am J Surg Pathol 2003;27:1269-1277.
44. Zinzani PL, Carrillo G, Ascani S, et al. Primary bone lymphoma: Experience with 52 patients. Haematologica 2003;88:280-285.
45. Barbieri E, Cammelli S, Mauro F, et al. Primary non- Hodgkin's lymphoma of the bone: treatment and analysis of prognostic factors for Stage I and Stage II. Int J Radiat Oncol Biol Phys 2004;59:760-764.
46. Beal K, Allen L, Yahalom J. Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients. Cancer 2006;106:2652-2656.
47. Horsman JM, Thomas J, Hough R, et al. Primary bone lymphoma: A retrospective analysis. Int J Oncol 2006;28: 1571-1575.
48. Catlett JP, Williams SA, O'Connor SC, et al. Primary lymphoma of bone: An institutional experience. Leuk Lymphoma 2008;49:2125-2132.
49. Mendenhall NP, Jones JJ, Kramer BS, et al. The management of primary lymphoma of bone. Radiother Oncol J Eur Soc Ther Radiol Oncol 1987;9:137-145.
50. Brousse C, Baumelou E, Morel P. Primary lymphoma of bone: A prospective study of 28 cases. Joint Bone Spine 2000;67:446-451.
51. Shannon JA, Bell DR, Levi JA, et al. Bone presentation of non-Hodgkin's lymphoma: Experience at the Royal North Shore Hospital, Sydney; highlighting primary bone lymphoma. Aust N Z J Med 1994;24:701-704.
52. Zucca E, Roggero E, Bertoni F, et al. Primary extranodal non- Hodgkin's lymphomas. Part 2: head and neck, central nervous system and other less common sites. Ann Oncol 1999;10: 1023-1033.
53. Miller TP, Dahlberg S, Cassady JR, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med 1998;339:21-26.
54. Horning SJ, Weller E, Kim K, et al. Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non- Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484. J Clin Oncol 2004;22:3032-3038.
55. Miller TP, LeBlanc M, Spier CM. CHOP alone compared to CHOP plus radiotherapy for early stage aggressive non- Hodgkin's lymphomas: uptodate of the Southwestern Oncology Group (SWOG) randomized trial. Blood 2001;98:724a.
56. Bonnet C, Fillet G, Mounier N, et al. CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: A study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 2007;25:787-792.
57. Reyes F, Lepage E, Ganem G, et al. ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. N Engl J Med 2005;352:1197-1205.
58. Feugier P, Van Hoof A, Sebban C, et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: A study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 2005;23:4117-4126.
59. Pfreundschuh M, Trumper L, Osterborg A, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-Bcell lymphoma: A randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 2006;7:379-391.
60. Sehn LH, Donaldson J, Chhanabhai M, et al. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol 2005;23:5027-5033.